Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
主要な著者: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
その他の著者: | International College of Geriatric Psychoneuropharmacology |
フォーマット: | Journal article |
言語: | English |
出版事項: |
John Wiley & Sons, Ltd.
2010
|
主題: |
類似資料
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
著者:: Oulhaj, A, 等
出版事項: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
著者:: Smith, A, 等
出版事項: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
著者:: de Jager, C, 等
出版事項: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
著者:: De Jager, C, 等
出版事項: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
著者:: Goodwin, G
出版事項: (2003)